Histone deacetylase inhibitors regulate the oral cancer via PI3K/AKT signaling pathway

Oral Oncol. 2022 Dec:135:106221. doi: 10.1016/j.oraloncology.2022.106221. Epub 2022 Oct 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Apoptosis
  • Cell Line, Tumor
  • Cell Proliferation
  • Histone Deacetylase Inhibitors* / pharmacology
  • Histone Deacetylase Inhibitors* / therapeutic use
  • Humans
  • Mouth Neoplasms* / drug therapy
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction

Substances

  • Histone Deacetylase Inhibitors
  • Proto-Oncogene Proteins c-akt
  • Phosphatidylinositol 3-Kinases